Suppr超能文献

黏膜黑色素瘤中 、 、 、 和 突变的预后作用。

Prognostic Roles of , , , and Mutations in Mucosal Melanomas.

机构信息

Department of Pathology, Poznan University Medical Sciences and Greater Poland Cancer Center, 61-701 Poznan, Poland.

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.

出版信息

Cells. 2021 Aug 27;10(9):2216. doi: 10.3390/cells10092216.

Abstract

BACKGROUND

The prognostic value of commonly recurrent mutations remains unclear in mucosal melanomas.

METHODS

Clinicopathologic parameters of 214 cases of mucosal melanomas diagnosed in 1989-2020 in several clinical institutions were analyzed. , , , and mutational analyses by Sanger sequencing and next generation sequencing-based assay were performed in a subset of cases.

RESULTS

Of the triple (, , )-negative cases, , and are detected mainly in sinonasal, vulvovaginal and anorectal melanomas, respectively. , , , and mutations are detected in 19% (37/198), 22% (44/197), 12% (25/201), 16% (22/138) and 15% (20/133) of cases, respectively. In univariate analyses, advanced stage ( = 0.016), 65 years or older ( = 0.048) and presence of ulceration ( = 0.027) are significantly correlated with worse overall survival (OS), respectively. mutation significantly correlates with worse OS ( = 0.028) and worse melanoma-specific survival (MSS) ( = 0.03) for all cases of mucosal melanomas. In multivariate analyses, mutation remains as an independent predictor of worse OS ( = 0.036) and worse MSS ( = 0.024).

CONCLUSION

mutation is a predictor of worse survival, independent of stage in mucosal melanomas. The significance of frequently mutated in mucosal melanomas remains unclear.

摘要

背景

在黏膜黑色素瘤中,常见复发突变的预后价值仍不清楚。

方法

分析了 1989 年至 2020 年在多个临床机构诊断的 214 例黏膜黑色素瘤患者的临床病理参数。对部分病例进行了 Sanger 测序和下一代测序的 、 、 、 和 突变分析。

结果

在三重(、、)阴性病例中,、和主要在鼻旁窦、外阴阴道和肛门直肠黑色素瘤中检测到。在 19%(37/198)、22%(44/197)、12%(25/201)、16%(22/138)和 15%(20/133)的病例中分别检测到 、 、 、 和 突变。单因素分析显示,晚期(=0.016)、65 岁或以上(=0.048)和溃疡存在(=0.027)与总生存(OS)较差显著相关。突变与所有黏膜黑色素瘤患者的 OS(=0.028)和 MSS(=0.03)较差显著相关。多因素分析显示,突变仍然是 OS(=0.036)和 MSS(=0.024)较差的独立预测因素。

结论

突变是生存的预测因素,与黏膜黑色素瘤的分期无关。在黏膜黑色素瘤中,频繁突变的 意义仍不清楚。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b8/8468625/9b8641539935/cells-10-02216-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验